just out: Why ACAD Has Alot of Upside Potential. /////////// post.
Apr 12 2013, 09:35 By: RC Jackson
investors should consider the Pimavanserin's potential not only in PDP, but also in other indications such as Alzheimer's disease psychosis, and when administered with antipsychotics for the treatment of schizophrenia and other mental illnesses.
\I see a bright future ahead for Acadia Pharmaceuticals.